Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- A Global Initiative to Center Humanity in AI Development
- Vivoryon Therapeutics to Share Insights on 2024 Performance
- Addex Therapeutics Acquires Rights to Develop ADX71149
- Unifiedpost Group's Insights for 2024: Annual Report Highlights
- Wereldhave Reports Strong Q1 Results Amid Market Challenges
- EfTEN United Property Fund Achieves Notable Profit Growth
- Empowering Women and Girls Ahead of World Hemophilia Day
- Strava's Strategic Move: Using Runna to Enhance Training
- Coway Achieves Stunning 19th Year of Red Dot Design Success
- Strava Expands Its Offerings by Acquiring Runna App
- Liven AS Launches New Development Project in Tallinn Area
- IHS, LLC Expands Healthcare Horizons with OA Center Acquisition
- Exploring Wuhan's Wetlands: A Symphony of Wildlife and Nature
- Ad Council Welcomes New Board Members to Expand Impact
- Key Insights from Recent Economic Trends and Predictions
- Unveiling PHOMI eDisplay: The Future of Architectural Innovation
- Discover Innovative Automotive Solutions at Taipei AMPA 2025
- HTX Integrates Fireblocks, Elevating Security in Institutional Trading
- Revolutionizing Breast Cancer Treatments with 3D Pathology Insights
- Investigation of Key Companies Amid Shareholder Concerns
- Investigation of Shareholder Rights at LENSAR and Others
- Investigation of Shareholder Rights in Key Companies
- Exploring Shareholder Rights in Recent Corporate Transactions
- Investor Concerns Rise as Shareholder Investigations Begin
- GAC Showcases Innovative Mobility Solutions at Canton Fair
- Unlock Major Savings: Monport's Exclusive Prime Day Offers
- XCMG Technician College Fuels Global Talent Development Efforts
- Chaoyang District: A Hub for Global Talent and Innovation
- Fangzhou Innovations in AI for Hepatitis Control and Prevention
- Rio Tinto and AMG Team Up for Sustainable Aluminium Project
- Mesoblast Expands Ryoncil® Coverage to Over 100 Million Lives
- KOIL Energy's Exciting Presentation at Planet MicroCap Showcase
- Everbright Digital Holding Limited's IPO Journey Begins with Pricing
- Global Expansion of LG PuroTec: Innovations in Antimicrobial Glass
- Fosun International: Leading the Way in Sustainability Rankings
- Transforming Urban Spaces: LG CNS's Smart City Solutions
- Strengthening Bilateral Relations: The China-Malaysia Journey
- BigBear.ai Holdings, Inc. Investors Alerted to Legal Action
- Chang Gung Memorial Hospital's Groundbreaking Nerve Repair in Surgery
- Investors Encouraged to Join Ultra Clean Holdings Class Action
- Euronet's Upcoming Earnings Release and Growth Highlights
- Understanding Your Rights in the Firsthand Technology Fund Lawsuit
- Advent Technologies Faces Compliance Notice from Nasdaq
- Fation's Nosca9 Cleanser: A Game Changer in K-Beauty
- Unveiling the Innovative 2025 Chevy Equinox EV for Drivers
- Spring Health Boost: VARON's Oxygen Solutions at Great Discounts
- CHAI Emerges as Leader in Social AI, Outshining Competitors
- Converge Secures Final Approval for H.I.G. Capital Acquisition
- Recharge Launches Innovative AI-Powered SMS Service for Brands
- Pardee Resources Completes Sale of Oil and Gas Assets Successfully